Listed pharmaceutical companies’ market capitalization evaporated by KRW 11.64 trillion in 3 months

As the bubble in pharmaceutical and biopharmaceutical stocks has been controversy in the second half of the year, it was observed market capitalizations of domestic listed pharmaceutical companies(including biopharmaceutical and holding companies) have been reduced by more than KRW 11 trillion for the past 3 months.

It was also observed there have been more pharmaceutical companies which were ...